与其他固体瘤相比,在质瘤患者中保持疫苗诱导的免疫力
Alexander Yuile1,2,3,4, Joe Q Wei2,5, Kelly J McKelvey1,6
1Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, Royal North Shore Hospital, Northern Sydney Local Health District, St. Leonards, NSW, 2065, Australia.
Journal of neuro-oncology
|October 15, 2025
概括
质瘤患者对DNA和mRNA疫苗表现出有希望的免疫反应,这表明未来质瘤疫苗治疗的可行性. 这项研究通过评估对COVID-19疫苗的免疫反应来模拟潜在的癌症治疗方法.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 质瘤在成人初级脑瘤中是一个重大挑战.
- 治疗的局限性包括血脑屏障,瘤异质性和免疫抑制的微环境.
- 瘤疫苗有潜力,但它们在质瘤患者中的有效性尚不确定.
研究的目的:
- 评估质瘤患者对腺病毒DNA和mRNACOVID-19疫苗的免疫反应.
- 以此作为评估基于质瘤的疫苗疗法的模型.
- 为了比较质瘤患者,其他癌症患者和健康志愿者之间的免疫反应.
主要方法:
- 招募了COVID-19天真质瘤,非质瘤固体瘤患者和健康的志愿者.
- 在接种疫苗前和接种疫苗后的多个时间点收集的血液样本 (包括增剂).
- 通过ELISA和ELISPOT测试评估了SARS-CoV-2的特定免疫反应.
主要成果:
- 在第二剂后1个月的血清转化没有显著差异.
- 与健康志愿者相比,3个月后,质瘤和非质瘤患者的血清转化率明显较低.
- 在瘤患者和健康志愿者之间,可比的疫苗疗效和类似的B细胞和T细胞记忆反应.
结论:
- 质瘤患者表现出对DNA和mRNA疫苗产生显著免疫反应的能力.
- 这些发现支持开发质瘤特定疫苗疗法的可行性.
- 对基于质瘤的疫苗策略进行进一步研究是有必要的.
更多相关视频
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
16.5K
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.4K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
960
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
960
